Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07331740

Development and Application of a Parenting Anxiety Intervention Program for Young and Middle-Aged Female Breast Cancer Patients

This feasibility study aims to develop and test an intervention program for young and middle-aged female breast cancer patients who experience parenting concerns. Eligible participants will receive the tailored support program (including psychological counseling and parenting guidance). The study will assess whether the program is acceptable, feasible, and potentially helpful in reducing parenting concerns among this group.We plan to enroll 20 participants from Shanghai Zhoupu Hospital between March 2026 and October 2026.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–59 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clear breast cancer patients confirmed by histopathology who have received surgical treatment
  • Aged 18 to 59 and currently raising at least one minor child under the age of 18
  • Clinical stage I - IV
  • Be aware of the condition, provide informed consent and voluntarily participate in this study
  • The patient can cooperate with the research independently and has normal reading, comprehension, thinking and judgment abilities

Exclusion criteria

  • Concurrent with other cancers
  • Engaged in psychology work, or having received psychological intervention guidance within the past six months
  • Participate in other nursing intervention studies simultaneously

Treatment and study plan

Parenting Concerns Support Program

Behavioral

A 6-week program including 2 individual psychological counseling sessions and 4 group parenting guidance activities, designed to reduce parenting concerns in young and middle-aged female breast cancer patients.

Primary outcomes

  1. Parenting Concerns Scale for Breast Cancer Patients

    Time frame: Baseline (pre-intervention) , 6 weeks post-intervention (end of the program) and One month after the intervention ended

    This scale was developed by Qian Meiyan et al. in 2024 to assess the parenting anxiety level of breast cancer patients. The scale mainly consists of 5 dimensions and 25 items, namely disease communication (5 items), children's health (4 items), children's emotions (6 items), role communication (6 items), and family support (4 items).

Secondary outcomes

  1. Parenting Sense of Competence Scale

    Time frame: Baseline (pre-intervention), 6 weeks post-intervention (end of the program) and One month after the intervention ended

    This scale was created by Gibaud-Wallston in 1977, aiming to assess the self-perception and confidence level of caregivers.

  2. Herth hope index

    Time frame: Baseline (pre-intervention) , 6 weeks post-intervention (end of the program) and One month after the intervention ended

    Compiled by American scholar Herth in 1991, it is applicable to the survey of hope levels among healthy or sick adults. This scale continues to consist of 3 dimensions and 12 items, namely positive attitudes towards reality and the future, taking positive actions, and maintaining close relationships with others.

Sponsors and collaborators

Lead sponsor

Shanghai University of Traditional Chinese Medicine

Other

Registry information

Official study title

Parenting Concerns of Young and Middle-aged Women With Breast Cancer: A Study Protocol for a Feasibility Trial

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jan 12, 2026
Registry last updated
Jan 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.